Independent batch analysis
Batch Verification
Passed all tests
99.26%
Batch average by RP-HPLC
9.09 mg
Batch average across three vials
Confirmed
Compound identity result
No growth
Reported sterility result
0.08 EU/mL
LAL test result
<0.1 ppm
As 0.053 | Cd 0.006 | Pb 0.029 | Hg 0.032 ppm
Results are specific to batch TES-260701-M3 and should not be generalized to any other lot. Review the complete certificate for full methods and results.
Product overview
Tesamorelin 10 mg Research Material
Tesamorelin is described in scientific literature as a synthetic analogue of growth hormone-releasing hormone (GHRH). Research has examined its interaction with growth-hormone signalling in defined experimental and clinical contexts.
This Peptora product is supplied as lyophilized peptide material with a labelled quantity of 10 mg per vial. Elementrix reports a batch-average net content of 9.09 mg across three sampled vials.
Published studies listed below are provided strictly as scientific background. They do not establish that Peptora’s material is suitable for clinical use, and they are not instructions or recommendations for human or veterinary use.
Research Context at a Glance
Published scientific literature describes Tesamorelin through growth-hormone-releasing hormone analogue research:
Peptide signalling research
Batch-specific analysis
This summary describes the investigational mechanism reported in scientific literature. It is not a statement of intended use for this laboratory material.
Batch documentation
Traceable From Product to Certificate
The product, batch identifier and Elementrix report are presented together so researchers can review the applicable certificate before ordering.
- ✓ Batch-specific COA available online
- ✓ Direct Elementrix verification link
- ✓ Reported purity, identity and net content
Expanded third-party review
More Than a Purity Percentage
This batch certificate reports identity, net content, sterility, endotoxin and heavy metals alongside purity—providing six documented checkpoints.
The Peptora testing difference
We Test Beyond Purity
A purity percentage is only one part of a meaningful batch review. For batch TES-260701-M3, Elementrix also reports identity, net content, sterility, endotoxin and heavy metals.
✓ Net content
✓ LC-MS identity
✓ Sterility
✓ Endotoxin
✓ Heavy metals
One batch-specific Elementrix certificate with direct verification.
What the expanded panel covers
Purity and content
RP-HPLC purity of 99.26% and average net content of 9.09 mg are reported, including individual results from three sampled vials.
Identity confirmation
LC-MS analysis is reported as confirming the identity of the material evaluated by Elementrix.
Sterility and endotoxin
The certificate reports no growth for sterility and an endotoxin result of 0.08 EU/mL.
Heavy-metals screening
Arsenic, cadmium, lead and mercury are itemized at 0.053, 0.006, 0.029 and 0.032 ppm, with overall heavy metals below 0.1 ppm.
Identity confirmation
LC-MS identity is reported as confirmed for the Tesamorelin sample analyzed by Elementrix.
Direct verification
Report ELX-20260701-54287 can be checked through Elementrix so the certificate is not dependent on Peptora’s description alone.
Product care and fulfilment
Storage and Shipping
Storage
The Elementrix certificate for this batch does not state a storage temperature. Follow the product packaging and your laboratory’s validated storage and handling protocol.
Do not use the vial if its packaging or integrity appears compromised.
Ships from Ontario
Orders are fulfilled from Ontario, Canada. Review Peptora’s shipping information for current processing, delivery and order-handling details.
Documentation built in
Why Choose Peptora?
Peptora Peptide Labs is structured around transparent, batch-specific documentation for Canadian laboratory researchers.
Independent analysis
Testing results are documented through a third-party Elementrix certificate rather than an internal specification sheet alone.
Batch-specific COAs
The displayed certificate is tied to a defined report number and batch identifier for straightforward traceability.
Direct verification
Researchers can open the complete PDF and follow the independent verification link from the product page.
Canadian fulfilment
This research material ships from Ontario, Canada.
Clear intended use
Product presentation and documentation clearly identify the material as intended only for laboratory research.
Accessible documentation
Testing standards, certificates and product information are organized for review before ordering.
Product questions
Frequently Asked Questions
Clear answers about Tesamorelin 10 mg, its batch documentation, independent testing and intended use.
Important product restriction
For Laboratory Research Use Only
All Peptora Peptide Labs products are intended solely for controlled laboratory research. This material is not for human or veterinary consumption and is not intended for compounding, clinical use, diagnosis, treatment, cure or prevention of disease.
Peptora does not provide medical advice, dosing instructions, administration guidance or treatment recommendations.
Scientific background references
- Falutz J, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. New England Journal of Medicine. 2007.
- Stanley TL, et al. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial. JAMA. 2014.
- Stanley TL, et al. Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men. Journal of Clinical Endocrinology & Metabolism. 2011.
References are provided for scientific background only. Published research does not validate this specific Peptora batch or authorize clinical use of this research product.
